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Understanding Vaccine Hesitancy 
and How to Address It
Messaging to the Public about Vaccines: 
The Evidence Base and Lessons Learned
What Is Vaccine 
Confidence?




Refers to the trust that parents, patients, or HCPs have 
in:
• Recommended vaccinations
• Providers who administer vaccines
• Processes that lead to vaccine licensure and the 
recommended vaccination schedule
Vaccine Confidence1
Refers to delay in the acceptance or refusal of 
vaccination despite availability of vaccination services
Varies across time, place, and vaccines




1. National Vaccine Advisory Committee (NVAC). Public Health Rep. 2015;130(6):573–595. 2. Smith MJ. Infect Dis Clin North Am. 2015;29(4):759–769. 3. Allen A et al. The challenge of vaccination hesitancy and acceptance: an overview. In: Meeting the challenge of vaccine 







(refuse some, delay some, accept some)
Vaccine Confidence Spectrum1–3
7
Determinants of Vaccine Confidence1
HCP=health care provider.
1. National Vaccine Advisory Committee (NVAC). Public Health Rep. 2015;130(6):573–595.
Notable factors influencing parental confidence in, and acceptance of, childhood vaccines:
Thoughts that parents have regarding vaccine-preventable diseases, vaccine safety, vaccine 
effectiveness, and vaccination benefits
A provider’s confidence both in vaccines and in their ability to communicate effectively to 
parents about vaccines
The significant role that news and entertainment media and parents’ social network can play in 
influencing knowledge, beliefs, and behaviors associated with vaccines





Evolution of Vaccine Confidence in a Vaccine Program1























Who Is Lacking Vaccine 
Confidence?
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Vaccine Hesitancy and Undervaccination Are Observed in All Age Groups 
BRFSS=Behavioral Risk Factor Surveillance System; NIS=National Immunization Survey.
1. Hill H et al. MMWR Morb Mortal Wkly Rep. 2019;68(41):913–918. 2. Seither R et al. MMWR Morb Mortal Wkly Rep. 2019; 68(41);905–912. 3. Centers for Disease Control and Prevention (CDC). Flu vaccination coverage, United States, 2018–19 influenza season. 
cdc.gov/flu/fluvaxview/coverage-1819estimates.htm. Accessed August 14, 2020.
1.3% unvaccinated
(NIS-Child, N=25,059)
Children born during 2015–20161
2.5% with an exemption from ≥1 vaccine
(2018–2019 school year, N=3,643,598)
54.7% unvaccinated against influenza




Vaccine Hesitancy and Undervaccination Are Observed in All Age Groups 
NIS=National Immunization Survey.
aNote that CDC has transitioned to reporting NIS-Child data aby birth year rather than survey year.
1. Elam-Evans LD et al. MMWR Morb Mortal Wkly Rep. 2014;63(34):741–748. 2. Hill H et al. MMWR Morb Mortal Wkly Rep. 2015;64(33):889–896. 3. Hill H et al. MMWR Morb Mortal Wkly Rep. 2016;65(39):1065–1071. 4. Hill H et al. MMWR Morb Mortal Wkly Rep. 
2017;66(43):1171–1177. 5. Hill H et al. MMWR Morb Mortal Wkly Rep. 2018;67(40):1123–1128. 6. Hill H et al. MMWR Morb Mortal Wkly Rep. 2019;68(41):913–918. 7. Centers for Disease Control and Prevention (CDC). ChildVaxView. cdc.gov/vaccines/imz-
managers/coverage/childvaxview/interactive-reports/dashboards/2013-2014.html.  Accessed September 3, 2020. 8. Healthy People 2030. health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/reduce-proportion-children-who-get-no-recommended-
vaccines-age-2-years-iid-02. Accessed September 4, 2020.
Estimated percentage of unvaccinated children 
aged 19–35 months, 












Estimated Percentage of Unvaccinated Children
















Estimated percentage of unvaccinated children 





Vaccine Hesitancy and Undervaccination Are Observed in All Age Groups 
1. Seither R et al. MMWR Morb Mortal Wkly Rep. 2015;64(33):897–904. 2. Seither R et al. MMWR Morb Mortal Wkly Rep. 2016;65(39):1057–1064. 3. Seither R et al. MMWR Morb Mortal Wkly Rep. 2017;60(40):1073–1080. 4. Mellerson JL et al. MMWR Morb 
Mortal Wkly Rep. 2018;67(40):1115–1122. 5. Seither R et al. MMWR Morb Mortal Wkly Rep. 2019; 68(41):905–912. 
Estimated median percentage of children enrolled in kindergarten with an exemption 
















(N=3,829,686) (N=3,791,755) (N=3,666,870) (N=3,634,631) (N=3,643,598)
Kindergarteners
13
Vaccine Hesitancy and Undervaccination Are Observed in All Age Groups 
BRFSS=Behavioral Risk Factor Surveillance System.
1. Centers for Disease Control and Prevention (CDC). Flu vaccination coverage. United States, 2014-15 influenza season. cdc.gov/flu/pdf/fluvaxview/NFID-coverage-2014-15-final.pdf. Accessed August 14, 2020. 2. CDC. Flu vaccination coverage. United States, 2015-16 influenza
season. cdc.gov/flu/pdf/fluvaxview/2015-16/nfid-coverage-2015-16-final.pdf. Accessed August 14, 2020. 3. CDC. Flu vaccination coverage, United States, 2016–17 influenza season. cdc.gov/flu/fluvaxview/coverage-1617estimates.htm. Accessed August 14,2020. 4. CDC. 
Estimates of influenza vaccination coverage among adults—United States, 2017–18 flu season. cdc.gov/flu/fluvaxview/coverage-1718estimates.htm, Accessed August 14,2020. 5. CDC. Flu vaccination coverage, United States, 2018–19 influenza season. 
cdc.gov/flu/fluvaxview/coverage-1819estimates.htm. Accessed August 14, 2020.









2014–2015 2015–2016 2016–2017 2017–2018 2018–2019
Estimated percentage of adults aged ≥18 years unvaccinated against influenza, 













(N=323,215) (N=319,167) (N=325,801) (N=313,143) (N=302,148)
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responded “My attitude is positive—I believe that vaccines 
play an important role in healthcare” regarding vaccines for babies 
and young children
1. Data available on request from Merck, Professional Services-DAP, WP1-27, PO Box 4, West Point, PA 19486-0004. Please specify information package US-NON-05819.
Most Parents Have Positive Attitudes Toward Vaccines1
In an online survey, 4,369 parents of 7,984 children ages 0 to 18 years in the United States 
were asked about their general attitude towards vaccines
responded “My attitude is positive—I believe that vaccines 




















However, Many Individuals May Be Misinformed About Vaccines1,a
aSurvey of Americans conducted from February 28–March 25, 2019 and September 13–October 2, 2019 designed to study how anti-vaccination claims are widely held, persist, and relate to an individual’s media consumption and levels of trust in medical experts.
1. Stecula DA et al. How trust in experts and media use affect acceptance of common anti-vaccination claims. The Harvard Kennedy School (HKS) Misinformation Review. misinforeview.hks.harvard.edu/wp-content/uploads/2020/01/v2_vaccinessocialmedia_jan29-1.pdf. 
Accessed August 14, 2020.
Many who reported low trust in medical authorities 
also believed vaccine misinformation
mistakenly state that it is very or somewhat accurate to say that vaccines cause autism
mistakenly agree that it is very or somewhat accurate to say that vaccines are full of toxins
inaccurately report that it is very or somewhat accurate to say it makes no difference whether parents choose to delay or 
spread out vaccines instead of relying on the official CDC vaccine schedule






This belief in vaccine misinformation was true 
across different demographic groups and political beliefs
16
Vaccine Confidence May Vary Among Racial or Ethnic Groups
African American participants have a higher level of trust in HCPs who share similar racial, 
ethnic, or cultural backgrounds than in HCPs who do not3
HCP=health care provider.
1. Quinn S et al. PLoS Curr. 2016;8:ecurrents.outbreaks.3e4a5ea39d8620494e2a2c874a3c4201. 2. Centers for Disease Control and Prevention (CDC). Flu vaccination coverage, United States, 2018–19 influenza Season. cdc.gov/flu/fluvaxview/coverage-1819estimates.htm. 
Accessed August 14, 2020. 3. Fu LY et al. Hum Vaccin Immunother. 2019;15(7−8):1715−1722.
A study exploring racial differences in African Americans’ and Whites’ vaccine acceptance showed that1:
African American adults have lower confidence in vaccines than White adults: the clearest racial divide is the level 
of trust in the government’s role in vaccination.
Cost is a greater barrier to vaccination uptake in African American adults than in 
White adults.
There are disparities in vaccination uptake among ethnic and racial groups in the United States1,2
17
Factors that can increase 
HCPs’ confidence in 
vaccines1:
Vaccine Hesitancy Also Exists With Health Care Providers
HCP=health care provider.
1. Paterson P et al. Vaccine. 2016;34(52):6700−6706. 2. Suryadevara M et al. Vaccine. 2015;33(48):6629−6634.





Questionnaires completed anonymously by 680 HCPs regarding their views on vaccination showed that2:
5%












1. Amin AB et al. Nat Hum Behav. 2017;1(12):873–880.
The Types of Mistrust May Be Rooted in Human Psychology1
The Moral Foundation Theory proposes that a set of innate intuitions lead humans to certain emotional responses to particular 
interpersonal events. Six foundations have been shown to be involved in vaccine hesitancy:
Purity and liberty assumptions predict hesitancy
Medium-hesitancy parents were twice as likely as 
low-hesitancy parents to highly emphasize purity
High-hesitancy parents were twice as likely as 
low-hesitancy parents to strongly emphasize
purity and liberty
Foundation Relation to vaccine hesitancy
Care/harm May underlie concerns about the harm that might result from vaccines, particularly if it affects vulnerable children
Authority/subversion May be associated with distrust of scientists and government officials who promote vaccinations
Liberty/oppression May be associated with the belief that mandatory vaccination policies violate parental civil liberties
Purity/degradation May underlie concerns that vaccines are unnatural and that exposing children to diseases “naturally” is preferable
Fairness/cheating
May fuel outrage in response to the perception that pharmaceutical companies motivated by profit have an unfair voice in vaccine
policy
Loyalty/betrayal






1. Brewer NT et al. Psychol Sci Public Interest. 2017;18(3):149–207.
Vaccination Uptake Is Influenced by 3 Psychological Realms1
o Include risk beliefs and anticipated 
regret
o Correlate to getting vaccinated
o Can motivate but the impact on 
actual vaccination behavior is not 
known
o Are influenced by:
• Patient/provider and 
parent/child relationships
• Social networks and social norms
o Can motivate through desire to 
protect others or defer vaccination 
by taking advantage of the protection 
provided by others  
o Bypassing any attempt to change 
what people think and feel
o Direct interventions on behavior 
without trying to change thoughts 
and feelings or social context are 
effective
o Incentives, sanctions, and 





1. Nabet B et al. Addressing vaccine hesitancy to protect children and communities against preventable diseases. PolicyLab at Children’s Hospital of Philadelphia;2017. policylab.chop.edu/sites/default/files/pdf/publications/Addressing_Vaccine_Hesitancy.pdf. Accessed August 
14, 2020. 2. Smith MJ. Infect Dis Clin North Am. 2015;29(4):759–769. 3. Hough-Telford C et al. Pediatrics. 2016;138(3):e20162127. 4. Thomson A et al. Vaccine. 2016;34(8):1018–1024.
Challenges and Factors of Vaccine Hesitancy
Access, affordability, awareness, acceptance, and activation
Key challenges to hesitancy1
Diminished prioritization 
of vaccination1
Lack of uniform 





Lack of confidence 
in vaccine safety 
and efficacy1
Factors influencing vaccination uptake4:
What Are Some 
Possible Solutions?
22
1. Centers for Disease Control and Prevention (CDC). Immunization strategies for healthcare practices and providers. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 
2015:33–46. 2. Reich JA. Soc Sci Med. 2016;157:103−110. 3. Offit PA et al. Pediatrics. 2002;109(1):124−129. 4. Brewer NT et al. Psychol Sci Public Interest. 2017;18(3):149−207. 5. National Vaccine Advisory Committee (NVAC). Public Health Rep. 2015;130(6):573−595. 
Remind Patients About the Power to Help Protect 
Viruses and bacteria that cause vaccine-
preventable diseases still exist and can be 
transmitted by unprotected persons1
Vaccinations protect the individual 
vaccinated and those around them4,5
Community protection5:
When high levels of immunity in a community are induced by 
vaccination, a person with a transmissible, vaccine-
preventable disease is unlikely to find a susceptible host to 
continue the transmission5
Vaccine coverage within the community must be high to 
achieve and sustain protection of those vulnerable to the 
disease, including children and those with underlying 
medical conditions4,5
Infection may lead to illness and 
complications, which can be serious and life-
threatening2,3
Outbreaks of vaccine-preventable diseases 
still occur2
23
Educate Patients About the Risks and Benefits of Vaccines1
CDC=Centers for Disease Control and Prevention; FDA=Food and Drug Administration.











Considerations for vaccine 
recommendation:
How safe and effective is 
the vaccine at specific ages?
How serious is the disease 
it prevents?
How many people would get the 
disease if there was no vaccine?
Vaccine Adverse Event 
Reporting System (VAERS)






FDA only licenses a vaccine if it 
is safe and effective and its 
benefits outweigh its risks
The FDA sets rules for 3 phases of clinical trials which test for the safety and efficacy of a 
new vaccine prior to licensure. The traditional phases include:
If licensed, CDC carefully reviews all data about the vaccine from clinical trials and other 
studies to develop recommendations for the vaccine’s routine use
After licensure and recommendation, FDA and CDC continue to monitor vaccine safety
24
1. Brewer NT et al. Psychol Sci Public Interest. 2017;18(3):149−207. 2. Dudley MZ et al. Vaccine 2020;38(4):709−711. 3. Schoeppe J et al. Health Promot Pract. 2017;18(5):654–661.
Words Matter in Vaccine Advocacy and Communication 
Words matter when trying to achieve a common goal of healthy communities through optimal vaccination uptake2
Vaccine decision-making may be an 
emotional experience that is informed by 
thoughts and feelings1
Using words that are easily misinterpreted or 
that put people into categories may counter the 
goal of achieving high vaccine coverage and 
community support for vaccination2
“vaccine hesitancy” “anti-vaccine”
“anti-vaxxer”
“herd immunity” “mandatory vaccination”
“vaccine demand”
Engaging in positive talk and addressing concerns 
about vaccines is helpful1,3
Widely used vaccination terms may elicit 
strong reactions and consequences2




1. Killikelly A. J Microbiol Biol Educ. 2018;19(1):19.1.31. 2. Pluviano S et al. PLoS One. 2017;12(7):e0181640. 3. Kitta A & Goldberg DS. Crit Public Health. 2017;27(4):506–514.
The Information-Deficit Model
o There is a lack of evidence supporting the presumption that 
hesitancy and/or opposition are primarily driven by insufficient 
understanding of the facts3
o Providing more information may unintentionally cause 
those presented with the facts to hold more tightly to their 
opposing beliefs1
The information-deficit model suggests 
that vaccine hesitancy and/or refusal 
may be due to a lack of understanding 
that can be overcome with educational 
intervention1–3:
For example, “if only the public 
would understand the dangers 
of this disease, they would 
vaccinate against it”1
Communication of scientific facts alone is 
unlikely to improve vaccine confidence1
27
1. Chan MS et al. Psychol Sci. 2017;28(11):1531−1546. 2. Pluviano S et al. PLoS One. 2017;12(7):e0181640. 3. Dudley MZ et al. Vaccine 2020;38(4):709−711. 
Correcting Vaccine Misinformation
Corrective strategies may have unintended opposite effects, reinforcing misconceptions and reducing intentions to vaccinate2
If well handled (using terms that accurately represent their intended meaning), conversation addressing patient concerns about vaccination 
can lead to greater understanding of the benefits and risks and the importance of vaccination. 
This conversation may correspond with positive influences on vaccine acceptance and coverage.3
Vaccine misinformation may lead 
to poor decision-making, with 
potentially serious implications1,2
Meta-analyses have shown that 
vaccine misinformation may persist 
and be difficult to correct1,2
Countering false vaccine information 
in ways that repeat it (eg, myths vs 




aBased on a nationally representative survey of 1005 US adults ≥19 years old and older.
1. Opel DJ et al. Pediatrics. 2013;132(6):1037–1046. 2. Nabet B et al. Addressing Vaccine Hesitancy to Protect Children and Communities Against Preventable Diseases. PolicyLab at Children’s Hospital of Philadelphia;2017. 
policylab.chop.edu/sites/default/files/pdf/publications/Addressing_Vaccine_Hesitancy.pdf. Accessed August 14, 2020. 3. CDC. Immunization Strategies for Healthcare Practices and Providers. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine-
Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015:33–46. 4. Nowak GJ et al. Int J Environ Res Public Health. 2018;15(4):711.
Deliver a Strong Recommendation
The use of presumptive 
language has been shown 
to be an effective way to 
increase vaccination 
uptake1
A strong provider recommendation is a key predictor of a patient receiving a vaccine 
and can significantly increase vaccination rates2,3
Presumptive formats presuppose 
that parents will vaccinate
“We have some shots to do today.”
Participatory formats provide parents 
with more decision-making latitude
“Are we doing shots today?”
VS
Two-thirds of patients who received a provider recommendation for influenza vaccine received the vaccine 
within 12 months; 84% of those without a recommendation remained unvaccinated4,a
29
1. Dempsey AF & O’Leary ST. Acad Pediatr. 2018;18(2S):S23–S27. 2. Miller WR et al. The method of motivational interviewing. In: Miller WR, Rollnick S, eds. Motivational Interviewing: Helping People Change. 3rd ed. New York, NY: The Guilford Press; 2013:25–36.
Suggested Flow of Vaccine Communication1,2
Make a strong recommendation






















aMotivational interviewing requires specialized training to be effective.
1. Rollnick S et al. Motivational interviewing principles and evidence. In: Rollnick S et al, eds. Motivational Interviewing in Health Care: Helping Patients Change Behavior. New York, NY: The Guilford Press. 2008;3–10. 2. Miller WR et al. The method of motivational interviewing. 
In: Miller WR, Rollnick S, eds. Motivational Interviewing: Helping People Change. 3rd ed. New York, NY: The Guilford Press; 2013:25–36. 3. Reno JE et al. J Health Commun. 2018;23(4):313–320.
Spirit and Core Skills of Motivational Interviewing
Motivational interviewing is a guiding style of communication, 
built around 3 components1,a
O-A-R-S
are the core communication skills for motivational interviewing2,3
Collaboration: 
Using a comfortable, non-confrontational tone 
and language
Evocation: 
Leading patients (or parents) to draw their 
own conclusions
Honoring patient’s autonomy: 
Supporting patients in making their own decisions
Open-ended questions
“What concerns do you have about vaccines?”O
Affirmations 
“You have thought a lot about this.”A
Reflective listening




HCP=health care provider; MI=motivational interviewing. 
1. Miller WR et al. Conversations about change. In: Miller WR, Rollnick S, eds. Motivational interviewing: helping people change. 3rd ed. New York, NY: The Guilford Press; 2013:3–13. 2. Miller WR et al. Ambivalence. Change talk and sustain talk. In: Miller WR, Rollnick S, eds. 
Motivational interviewing: helping people change. 3rd ed. New York, NY: The Guilford Press; 2013:157–166. 3. Westra HA &Aviram A. Psychotherapy (Chic). 2013;50(3):273–278. 4. Miller WR et al. Responding to sustain talk and discord. In: Miller WR, Rollnick S, eds. 
Motivational interviewing: helping people change. 3rd ed. New York, NY: The Guilford Press; 2013:196–211. 
Using Motivational Interviewing to Foster Change
MI solution: evoking (eliciting patient’s own motivations for change), by strategically 
reflecting change talk over non-change talk2,3
MI solution: rolling with resistance and coming alongside, by reflecting on what you 
hear, trying to understand, and supporting autonomy3,4
Normal part of human nature and a step toward change1–3
Has 2 incompatible sides1–3:
• Reasons for change (change talk) 
• Reasons against change (sustain or non-change talk)
Must be resolved before moving to change1,2
Can be a form of resistance3
Could develop into resistance if HCP pushes too hard before patient is ready 
for change3




• Ignoring, not paying attention
• Crossing arms
• Being dismissive (“whatever”)
Ambivalence Resistance
Patient: “I think prevention is important, but I am worried about experiencing 
side effects.”
HCP: “You’re more than just a little worried about the side-effects of the 
vaccine, AND prevention is important to you. Tell me more about why 
prevention is a priority for you.”
Parent: “I think my child is too young for this vaccine. Someday, she may 
consider it, but not now.”
HCP: “It is hard for you to believe the vaccine is right for your child when she’s 
so young.”
“I can certainly understand why you feel that way. May I share the reasoning 
behind vaccinating early, and then you can tell me what you think?”
32
1. Miller WR, Rollnick S. Exchanging Information. In: Miller WR, Rollnick S, eds. Motivational Interviewing: Helping People Change. 3rd ed. New York, NY: The Guilford Press; 2013:131–154. 2. Reno JE et al. J Health Commun. 2018;23(4):313–320.
Motivational Interviewing Framework:
Use the Elicit–Provide–Elicit Script To Exchange Information1,2
Elicit Provide Elicit
Ask patients what they already know or 
would like to know more about
Ask them permission to 
offer information
Give information in a neutral, non-
judgmental way (avoid “I” and “you”)
Be clear, avoid jargon (eg, herd 
immunity3), and offer information in 
small amounts with time to reflect
Gather understanding from the patient of 
the information provided
Ask open questions and reflect on the  
patient’s reactions
What do you know about…?
What would you like to know about…?




So what do you make of that?
What else would you like to know?
What do you think is the next step for you?
33
1. Miller WR, Rollnick S. Evoking the person’s own motivation. In: Miller WR, Rollnick S, eds. Motivational Interviewing: Helping People Change. 3rd ed. New York, NY: The Guilford Press; 2013:167–182.
Readiness Ruler Gives an Opportunity for Evocative Questions1
102 3 4 5 6 7 8 9
On a scale from 0 to 10, where 0 means ‘not at all 
important’ and 10 means ‘the most important thing for me 





And why are 
you at a __ and 





1. National Vaccine Advisory Committee (NVAC). Public Health Rep. 2015;130(6):573–595. 2. Hill H et al. MMWR Morb Mortal Wkly Rep. 2018;67(40):1123–1128. 3. Seither R et al. MMWR Morb Mortal Wkly Rep. 2019; 68(41):905–912. 4. Centers for Disease Control and 
Prevention (CDC). ). Flu Vaccination Coverage, United States, 2018–19 Influenza Season. cdc.gov/flu/fluvaxview/coverage-1819estimates.htm. Accessed August 14, 2020. 5. Smith MJ. Infect Dis Clin North Am. 2015;29(4):759–769. 6. Thomson A et al. Vaccine. 2016;34(8):1018–
1024. 7. Nabet B et al. Addressing Vaccine Hesitancy to Protect Children and Communities Against Preventable Diseases. PolicyLab at Children’s Hospital of Philadelphia;2017. policylab.chop.edu/sites/default/files/pdf/publications/Addressing_Vaccine_Hesitancy.pdf. Accessed 
August 14, 2020. 8. CDC. The Journey of Your Child’s Vaccine. cdc.gov/vaccines/parents/infographics/journey-of-child-vaccine.html. Accessed August 14, 2020. 9. Amin AB et al. Nat Hum Behav. 2017;1(12):873–880. 10. Brewer NT et al. Psychol Sci Public Interest. 
2017;18(3):149–207. 11. Dudley MZ et al. Vaccine 2020;38(4):709−711. 12. Rollnick S et al. Motivational interviewing principles and evidence. In: Rollnick S et al, eds. Motivational Interviewing in Health Care: Helping Patients Change Behavior. New York, NY: The Guilford Press. 
2008;3–10. 13. Edwards KM et al. Pediatrics. 2016;139(3):e20162146. 14. Reno JE et al. J Health Commun. 2018;23(4):313–320.
Summary
Motivational interviewing tools may assist with 
conversations with vaccine hesitant patients or 
parents12–14
Providers and stakeholders must act to boost vaccine 
confidence and help reduce vaccine hesitancy, 
increasing vaccination rates to levels that will protect 
entire populations7
• Providers can focus on the benefits of vaccines, as well as 
vaccine safety and efficacy7,8
Vaccine hesitancy is present in all age groups2–4 and 
involves many factors and challenges, such as:
• Complacency, convenience, and confidence5
• Access, affordability, awareness, acceptance, activation6
When communicating with patients and parents, it is 
important to be mindful of how you discuss vaccines11
Vaccine confidence is an important factor for 
achieving and maintaining the high vaccination rates 
needed to sustain community-level protection against 
vaccine-preventable disease1
It is important to understand the causes of vaccine 
hesitancy when trying to increase vaccination 
uptake9,10
35
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Why has the anti vaccine movement been so successful?
• They are smaller numerically, but occupy a more central 
position in social media networks
• They message heavily and appeal to social media users who 
haven’t made up their mind about vaccines 
• They speak through “stories” rather than data
Harnessing the power of the anti vaccine movement 
• Occupying a central position in social media networks 
Massey PM, et al.  Dimensions of Misinformation About the HPV Vaccine on 
Instagram: Content and Network Analysis of Social Media Characteristics. J 
Med Internet Res. 2020.










































































Kearney MD, et al.  Characterizing HPV Vaccine Sentiments and Content on 
Instagram. Health Educ Behav. 2019
An opportunity for narrative engagement
• Narrative communication leverages the power of storytelling 
• Narratives strengthen knowledge, promote engagement, and provide 
mental and behavioral models 
• It does not present and defend arguments about how and why to achieve or 
avoid consequences related to health decisions or health care
• Rather, it amplifies feelings of empathy, transportation, and perceived 
similarity to strengthen the effects of narrative health messaging. 
• This is in contrast to non-narrative communication that utilizes expository 
and didactic styles, often presenting propositions in the form of reasons 
and evidence supporting a claim. 


From the CDC Social Media Toolkit: 
Less of these! More of these!
Q & A
Learn more at: Jefferson.edu/MPH   |   Questions: JCPH.Admissions@jefferson.edu
Classes Start 
September, January, or April
JCPH Virtual Open House
February 10 | 5:30-7:30 pm
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Visit our Website 
for more information 
Economic Evaluation of Vaccines: Challenges & Opportunities
February 17, 2021 | 12:00-1:00 pm ET
Register Now
The Five Myths About Poverty:
What you may think, and what we know…
March 3, 2021 | 12:00-1:00 pm ET
Register Now
Controlling High Blood Pressure:
An Evidence-Based Blueprint for Change
March 17, 2021 | 12:00-1:00 pm ET
Register Now
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